Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 107

Showing 26-50 of 107 citing articles:

Microneedle-based nanodrugs for tumor immunotherapy
Tianye Wang, Hongyu Liu, Meng Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 539-562
Closed Access
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape
Ashley L. Cook, Surojit Sur, Laura Dobbyn, et al.
eLife (2025) Vol. 13
Open Access
Self-assembly GSH response based peptide-drug nanocombination synergistically promotes DNA damage for prostate cancer immunotherapy
Maosong Hu, Yuyu Zhu, Xinyi Tang, et al.
Chemical Engineering Journal (2025), pp. 160862-160862
Closed Access
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Small non-coding RNA profiling in patients with non-muscle invasive bladder cancer
Jiajia Cai, Zeqin Yan, Yadi Zhong, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Epigenetic nanoplatform for synergistic immune activation and immunogenicity restoration enhancing cancer radio-immunotherapy
Zhenhu He, Xiaopei Peng, Jiong Li, et al.
Chemical Engineering Journal (2025), pp. 161177-161177
Closed Access
The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides
Deepa Bedi, Md. Imtaiyaz Hassan, Alehegne Yirsaw, et al.
Molecular & Cellular Oncology (2025) Vol. 12, Iss. 1
Open Access
Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis
Yuze Wu, Yuheng Yan, Yarong Guo, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Enhanced Tumor Ablation and Immune Activation Via Irreversible Electroporation and Functionalized Vermiculite Nanosheets
Runtan Li, Gaoli Niu, Yaoguang She, et al.
Small (2025)
Closed Access
Autophagy in tumor immune escape and immunotherapy
Huan Wang, Peng Sun, Xijing Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Steroid hormones as modulators of anti-tumoural immunity
Paul Schwarzlmüller, Alexandra Triebig, Guillaume Assié, et al.
Nature Reviews Endocrinology (2025)
Closed Access
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
Stephen L. Wang, Timothy A. Chan
Cancer Cell (2025)
Closed Access
Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
Xiaomeng Guo, Junqiang Bai, Xinmiao Wang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114576-114576
Closed Access
Genomics guiding personalized first-line immunotherapy response in lung and bladder tumors
Jenifer Brea-Iglesias, María Gallardo‐Gómez, Ana Oitabén, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
A Senescence-Associated Gene Signature for Prognostic Prediction and Therapeutic Targeting in Adrenocortical Carcinoma
Hangya Peng, Qiujing Chen, Lei Ye, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 894-894
Open Access
The diversity of CD8+ T cell dysfunction in cancer and viral infection
Lorenzo Galluzzi, Kellie N. Smith, Adrian Liston, et al.
Nature reviews. Immunology (2025)
Closed Access
Cancer diagnosis and treatment platform based on manganese-based nanomaterials
Jia Fei, Yanyan Liu, Ya Zeng, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 4
Dendronized Polymer‐Derived Nanomedicines for Mitochondrial Dynamics Regulation and Immune Modulation
Xingyu Hou, Dayi Pan, Dan Zhong, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 4
Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy
Rui Liang, Aoyu Cheng, Shengxin Lu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 7, pp. 2779-2789
Open Access | Times Cited: 4
Lipid Nanoparticle‐mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response
R.K. Das, Xinying Ge, Fan Fei, et al.
Small Methods (2024)
Open Access | Times Cited: 4
A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy
Keze Hong, Jianrong Cao, Weiting Jiang, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 750-762
Closed Access | Times Cited: 4
Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer
Tong Chen, Mingzhao Wang, Yanchao Chen, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The danger theory of immunity revisited
Guido Kroemer, Léa Montégut, Oliver Kepp, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 912-928
Closed Access | Times Cited: 4
Identification of a gene score related to antigen processing and presentation machinery for predicting prognosis in head and neck squamous cell carcinoma and its potential implications for immunotherapy
Xueliang Fang, Qingjie Li, Li Wang, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4

Scroll to top